Clinical Trials Directory

Trials / Conditions / Wet AMD

Wet AMD

11 registered clinical trials studyying Wet AMD — 5 currently recruiting.

StatusTrialSponsorPhase
RecruitingEfficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related M
NCT07482176
Adverum Biotechnologies, Inc.Phase 3
RecruitingEfficacy and Safety of LX102 Gene Therapy in Patients With Neovascular Age-related Macular Degeneration (nAMD)
NCT07317934
Innostellar Biotherapeutics Co.,LtdPhase 3
Active Not RecruitingNT-101 Topical Ophthalmic Solution in Patients With Wet AMD
NCT06704009
NexThera Co., Ltd.Phase 1 / Phase 2
RecruitingEfficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-Related M
NCT06856577
Adverum Biotechnologies, Inc.Phase 3
Enrolling By InvitationLong-Term Follow-Up Study of RGX-314 Administered in the Suprachoroidal Space for Participants With nAMD
NCT05210803
AbbVie—
RecruitingPivotal 1 Study of ABBV-RGX-314 (Also Known as RGX-314) Gene Therapy Administered Via Subretinal Delivery One
NCT04704921
AbbViePhase 2 / Phase 3
WithdrawnStudy to Evaluate the Safety and Effectiveness of IRay in Wet Age-related Macular Degeneration (AMD) Patients
NCT01339949
Oraya Therapeutics, Inc.N/A
UnknownGenetics Study of Wet Age-Related Macular Degeneration (AMD) Non-Responders to Vascular Endothelial Growth Fac
NCT01310686
West Coast Retina Medical Group, Inc.—
CompletedINTREPID - IRay Plus Anti-VEGF Treatment For Patients With Wet AMD
NCT01016873
Oraya Therapeutics, Inc.Phase 2
CompletedInvestigates Improvement in Vision Following Switching From Avastin and Macugen Over to Lucentis
NCT00804934
Retina Institute of Hawaii—
UnknownIntravitreal Bevacizumab for Retinal Disorders
NCT00403026
Narayana NethralayaN/A